IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA
Publication
, Conference
Shen, S; Reedy, J; Suryadevara, C; Hotchkiss, K; Snyder, D; Sanchez-Perez, L; Sampson, J
Published in: NEURO-ONCOLOGY
2021
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2021
Volume
23
Start / End Page
167 / 167
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shen, S., Reedy, J., Suryadevara, C., Hotchkiss, K., Snyder, D., Sanchez-Perez, L., & Sampson, J. (2021). IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA. In NEURO-ONCOLOGY (Vol. 23, pp. 167–167).
Shen, Steven, Jessica Reedy, Carter Suryadevara, Kelly Hotchkiss, David Snyder, Luis Sanchez-Perez, and John Sampson. “IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA.” In NEURO-ONCOLOGY, 23:167–167, 2021.
Shen S, Reedy J, Suryadevara C, Hotchkiss K, Snyder D, Sanchez-Perez L, et al. IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA. In: NEURO-ONCOLOGY. 2021. p. 167–167.
Shen, Steven, et al. “IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA.” NEURO-ONCOLOGY, vol. 23, 2021, pp. 167–167.
Shen S, Reedy J, Suryadevara C, Hotchkiss K, Snyder D, Sanchez-Perez L, Sampson J. IL-12 ARMORED CAR T CELL THERAPY FOR HETEROGENEOUS GLIOBLASTOMA. NEURO-ONCOLOGY. 2021. p. 167–167.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2021
Volume
23
Start / End Page
167 / 167
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences